Pfizer/BioNTech Covid-19 vaccine | The Business Standard

Coronavirus: On 16 November, 2020, US biotech company Moderna announced a vaccine against Covid-19 that is 94.5% effective. Montreal, 16 November, 2020/ Reuters

Coronavirus chronicle

Countries seek more Moderna, Pfizer/BioNTech Covid-19 shots as concerns mount over rival vaccines

Countries in Europe and Asia, as well as South Africa, are limiting or halting use of AstraZeneca's shot over safety concerns

Coronavirus chronicle

Hong Kong halts Pfizer/BioNTech Covid-19 vaccines, investigates defective packaging

Coronavirus chronicle

Swiss drugmaker Novartis to help make Pfizer-Biontech Covid-19 vaccine

US President Joe Biden speaks about the fight to contain the coronavirus disease (Covid-19) pandemic, at the White House in Washington, US January 26, 2021. REUTERS/Kevin Lamarque

Coronavirus chronicle

Biden administration aims to have enough vaccine for most Americans by summertime

The rushed lockdown was not compatible with the residents’ human rights, including their right to humane treatment when deprived of liberty..., the action appeared to be contrary to the law Photo: Collected

Coronavirus chronicle

Australia approves Pfizer vaccine, warns of limited global AstraZeneca supply

Coronavirus chronicle

Pfizer offers 40m Covid shots to poorer countries at cost

File Photo: Small bottles labelled with a "Vaccine Covid-19" sticker and a medical syringe are seen in this illustration taken April 10, 2020. Reuters/Dado Ruvic/Illustration/File Photo

Coronavirus chronicle

Covax announces new agreement, plans for first deliveries

This scanning electron microscope image shows SARS-CoV-2 (round blue objects), also known as novel coronavirus, the virus that causes Covid-19, emerging from the surface of cells cultured in the lab which was isolated from a patient in the US. Photo: Reuters

Coronavirus chronicle

Pfizer vaccine likely works against UK variant: Studies

Governor Andrew M. Cuomo. Photo: Collected

Coronavirus chronicle

New York governor asks Pfizer to directly sell Covid-19 vaccine doses

Pharmacist Susanne Wohlgemuth prepares Pfizer/BioNTech Covid-19 vaccinations at the Haus an der Linde nursing home in Lichtentanne, Saxony, Germany December 27, 2020, the day when the country starts its vaccination programme. Hendrik Schmidt/Pool via Reuters

Coronavirus chronicle

Norway to investigate 23 deaths in frail elderly patients after vaccination

Photo: Collected.

Coronavirus chronicle

Pfizer vaccine deliveries delayed in Europe: Oslo

Sandra Lindsay, a nurse at Long Island Jewish Medical Center, is inoculated with the coronavirus disease (Covid-19) vaccine by Dr Michelle Chester from Northwell Health at Long Island Jewish Medical Center in New Hyde Park, New York, US, 14 December, 2020. Reuters

Coronavirus chronicle

US distributes over 13.07m doses of Covid-19 vaccines; 4.2m administered

The first patient enrolled in Pfizer's COVID-19 coronavirus vaccine clinical trial at the University of Maryland School of Medicine in Baltimore. Pfizer and BioNTech say they've won permission Wednesday, Dec 2, 2020, for emergency use of their COVID-19 vaccine in Britain, the world’s first coronavirus shot that’s backed by rigorous science -- and a major step toward eventually ending the pandemic. Photo: Courtesy of University of Maryland School of Medicine via AP, File

Coronavirus chronicle

Pfizer and BioNTech to offer Covid vaccine to volunteers who got placebo